Opioid

Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus

Scientific article

28 February 2024

Abstract Background The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available treatments than 20 years ago, treatment access and high...

Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators

Scientific article

29 January 2024

Background People with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increasing rates of opioid...

“I’m almost opioid-a-phobic”: family medicine residents’ perceptions of enhancing opioid analgesic and agonist treatment training in a Canadian setting

Scientific article

9 May 2023

Purpose As deaths from the illicit drug poisoning crisis continue to rise in Canada, increasing the number of healthcare professionals qualified to effectively prescribe opioids could be beneficial. The willingness of family medicine...

PSMG: Reducing Opioid Use Disorder and Overdose in the United States: Model Development and Policy Analysis

Video and audio recordings

16 November 2021

Authors: Mohammad Jalali, PhD Harvard University Wayne Wakeland, PhD Portland State University Abstract: The opioid crisis is one of the most pressing public health issues in the U.S. today. Opioid overdoses are the proverbial “tip of the...

Integrating Opioid Use Disorder Treatment Into Primary Care Settings

Scientific article

11 August 2023

Abstract Importance Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist. Objective To evaluate an implementation intervention over 2 years to...

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021

Scientific article

7 August 2023

Discussion Despite guidelines recommending MOUD, approximately 1 in 5 adults with past-year OUD received any MOUD. Furthermore, some groups were substantially less likely to receive MOUD, in particular Black adults, women, those unemployed...

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

News

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...

Opioid Use Disorder in Pregnant and Postpartum People

31 May 2023

Washington, DC

United States

May 31, 2023, 03:00 PM (Washington, DC time)

Buprenorphine versus methadone for the treatment of opioid dependence

Scientific article

Summary Background Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...

International Conference on Opioids

6 July 2023

Stockholm

Sweden

The International Research Conference Aims and Objectives

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program.

Themes

Epidemiology and Etiology

Supply control

Emergency Resources